FATE icon

Fate Therapeutics
FATE

Overview Fund Activity

74 hedge funds and large institutions have $101M invested in Fate Therapeutics in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 5 closing their positions.

Holders
74
Holders Change
+14
Holders Change %
+23.33%
% of All Funds
1.85%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
18
Reduced
22
Closed
5
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$1K

Top Buyers

1
ECM
1
Endurant Capital Management
California
$1.08M
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$1.2M
3
Victory Capital Management
3
Victory Capital Management
Texas
$367K
4
6CM
4
683 Capital Management
New York
$2.69M
5
Neuberger Berman Group
5
Neuberger Berman Group
New York
$527K

Top Sellers

1
KCM
1
Kingdon Capital Management
New York
$1.53M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$15.7M
3
BI
3
BVF Inc
California
$0
4
EC
4
EcoR1 Capital
California
$8.96M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$871K
Name Market Value Shares Shares
Change 		Shares
Change %
Citigroup
76
Citigroup
New York
$0 70 -27 -28%
AIM
77
Acrospire Investment Management
Illinois
– – -22 Closed
Bank of Montreal
78
Bank of Montreal
Ontario, Canada
$0 17 +17 New
Simplex Trading
79
Simplex Trading
Illinois
$0 104 +104 New
1 2 3
4